WINDTREE THERAPEUTICS INC Purchase Agreements
13 Contracts & Agreements
- Form of Securities Purchase Agreement (Filed With SEC on July 29, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on July 22, 2024)
- Form of Securities Purchase Agreement by and between Windtree Therapeutics, Inc. and the Buyers named therein, dated April 2, 2024 (Filed With SEC on April 8, 2024)
- Form of Asset Purchase Agreement by and between Windtree Therapeutics, Inc. and Varian Biopharmaceuticals, Inc., dated April 2, 2024 (Filed With SEC on April 8, 2024)
- Amendment to No. 1 dated February 20, 2020 to the Securities Purchase Agreement dated December 6, 2019 by and among Windtree and the purchasers party thereto (Filed With SEC on April 3, 2020)
- Form of Securities Purchase Agreement, dated December 6, 2019 by and among the Company and the purchasers party thereto (Filed With SEC on December 9, 2019)
- Securities Purchase Agreement, dated December 21, 2018 by and among the Company and the purchasers named on Schedule I thereto (Filed With SEC on December 21, 2018)
- Securities Purchase Agreement dated March 30, 2018 (Filed With SEC on April 4, 2018)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 1, 2017)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 15, 2017)
- COMMONSTOCK PURCHASE AGREEMENT byand between KINGSBRIDGECAPITAL LIMITED and DISCOVERYLABORATORIES, INC. datedas of June 11, 2010 TABLEOF CONTENTS (Filed With SEC on June 14, 2010)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 22, 2006)
- ASSET PURCHASE AGREEMENT among LAUREATE PHARMA, INC. (a Delaware corporation), and DISCOVERY LABORATORIES, INC. (a Delaware corporation) TABLE OF CONTENTS (Filed With SEC on January 3, 2006)
